Literature DB >> 4326920

Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation.

E Simpson, S L Nehlsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4326920      PMCID： PMC1713002     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  37 in total

1.  Oncogenic effect of tissue-culture preparations of polyoma virus on fetal mice.

Authors:  M F STANTON; S E STEWART; B E EDDY; R H BLACKWELL
Journal:  J Natl Cancer Inst       Date:  1959-12       Impact factor: 13.506

2.  Studies of parotid-tumor agent in cultures of leukemic tissues of mice.

Authors:  C J DAWE; L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1959-10       Impact factor: 13.506

3.  The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors:  T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal:  Surg Gynecol Obstet       Date:  1967-02

4.  Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum.

Authors:  A C Allison; L D Berman; R H Levey
Journal:  Nature       Date:  1967-07-08       Impact factor: 49.962

5.  Immunosuppression in allogeneic murine tumour system. A model for the study of antilymphocyte serum.

Authors:  S D Deodhar; G Crile; P F Schofield
Journal:  Lancet       Date:  1968-01-27       Impact factor: 79.321

6.  Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum.

Authors:  E J Stanbridge; F T Perkins
Journal:  Nature       Date:  1969-01-04       Impact factor: 49.962

7.  Further experiments on the action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

8.  Absence of thymus in a mouse mutant.

Authors:  E M Pantelouris
Journal:  Nature       Date:  1968-01-27       Impact factor: 49.962

9.  Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice.

Authors:  D V Parrott; M A De Sousa; J East
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

10.  Histopathological effects in mice of heterologous antilymphocyte serum.

Authors:  R N Taub; E M Lance
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307
View more
  8 in total

1.  Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.

Authors:  S L Nehlsen
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

2.  Experimental glomerulonephritis in the mouse. II. Effect of antithymocyte globulin.

Authors:  P S Avasthi; P Avasthi; S Tokuda; R E Anderson; R C Williams
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

3.  The histological response to a xenogeneic tumour in mice.

Authors:  E Simpson; P C Beverley
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

Review 4.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

Review 5.  Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.

Authors:  E Gleichmann; H Gleichmann
Journal:  Klin Wochenschr       Date:  1973-03-15

6.  The effect of antilymphocytic antibody on the humoral immune response of different strains of mice. IV. Variable effect of individual ALG preparations on the immune response to type 3 polysaccharide antigen.

Authors:  A Ghaffar; K James
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

7.  Resistance to Rhipicephalus evertsi evertsi in immunosuppressed rabbits.

Authors:  B C Njau
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

8.  Evidence for a blood-thymus barrier using electron-opaque tracers.

Authors:  E Raviola; M J Karnovsky
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.